Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation

Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation

Abstract Atrial fibrillation (AF) is one of the most common arrhythmias in elderly people. The risk of thromboembolic stroke is increased in AF patients, especially those with diabetes. Anticoagulant therapy, such as warfarin and non-vitamin K oral anticoagulants (NOACs), is recommended for diabetic...

Full description

Bibliographic Details
Main Author: Sho-ichi Yamagishi
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Cardiovascular Diabetology
Subjects:
Advanced glycation end products
Atrial fibrillation
Bone fracture
Diabetes
Vascular calcification
Warfarin
Online Access:http://link.springer.com/article/10.1186/s12933-019-0818-0

Internet

http://link.springer.com/article/10.1186/s12933-019-0818-0

Similar Items